Charles Hoy (left), a patient with acute myeloid leukemia (AML), talks with his medical oncologist, Rizwan Romee, MD, of Washington University School of Medicine in St. Louis. Romee co-leads clinical trials evaluating a new immunotherapy…
QVC and FFANY present a contribution of $300,000 as a result of charitable multiplatform event For more than 20 years, QVC Presents “FFANY Shoes on Sale” has combined great shopping with an even better cause….
Quitting smoking improves health and lowers odds of developing lung cancer. But a new study shows that even among smokers with a genetic predisposition to smoking heavily and developing lung cancer at a young age,…
There’s yet another reason to maintain a healthy weight as we age. An international team of researchers has identified eight additional types of cancer linked to excess weight and obesity: stomach, liver, gall bladder, pancreas,…
Stephanie Markovina, MD, PhD, an assistant professor of radiation oncology, has received the 2016 Junior Faculty Career Research Training Award from the American Society for Radiation Oncology (ASTRO). She will receive a two-year, $200,000 grant as…
Evan Sadler, PhD, MD, a professor of medicine and director of the Division of Hematology at Washington University School of Medicine in St. Louis, will receive the 2016 Henry M. Stratton Medal for Basic Science….
The National Cancer Institute (NCI) has awarded a $10.4 million, five-year grant to Washington University researchers and physicians at Siteman Cancer Center to lead a national group of experts in collaborative pancreatic cancer research. The…
Many breast tumors grow in response to female hormones, especially estrogen. Drugs that reduce estrogen levels in the body often are effective in reducing tumor size and preventing recurrence of the cancer. But some tumors…
Jeff Michalski, MD, the Carlos Perez Distinguished Professor of Radiation Oncology at Washington University School of Medicine in St. Louis and a radiation oncologist at Siteman Cancer Center, has been elected radiation oncology co-chair of the…
The level of a specific molecule present in prostate tumors is an indicator of whether the cancer is aggressive and likely to spread, according to new research from Washington University School of Medicine in St….